Objective: We examined the relationship between gestational glycemia and neonatal adiposity in a multiethnic cohort of Singaporean neonates.
O
besity presents a massive health challenge as it rapidly becomes a worldwide epidemic (1) . Increasingly, recent evidence has pointed to significant relationships between hyperglycemia during pregnancy and increased adiposity and later life glucose intolerance in the offspring (2) . It is also well established that maternal hyperglycemia is associated with increased birth weight and macrosomia, and studies have identified its long-lasting effects on the offspring, resulting in higher obesity rates (3, 4) and type 2 diabetes (5). More recently the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) Study showed the effect of maternal glycemia on neonatal adiposity and adverse neonatal outcomes is continuous across the range of maternal glucose concentrations, even at levels below diagnostic criteria for gestational diabetes mellitus (GDM) (6, 7) . Both fasting and 2-hour postchallenge glucose levels contribute to GDM; however, the relative contributions of fasting and postchallenge hyperglycemia toward excessive neonatal adiposity remain uncertain. Past studies have shown that postchallenge glucose levels exhibit a strong linear relationship with adverse birth weight outcomes (large for gestational age or macrosomia) (7) (8) (9) . Other studies, however, reported fasting glucose levels were better than postchallenge levels in identifying risk of macrosomia (10, 11) . Recent diagnostic criteria by the International Association of Diabetes and Pregnancy Study Groups have highlighted the importance of fasting glucose in the detection and diagnosis of hyperglycemic disorders during pregnancy, which may in turn play a crucial role in identifying risk of excessive neonatal adiposity.
Growing Up in Singapore Towards healthy Outcomes (GUSTO) is a mother-offspring cohort study designed to test specific hypotheses related to the developmental pathways to obesity and cardiometabolic disorders in Chinese, Malay, and Indian participants (12) . One of GUSTO's major aims is to study developmental factors that can predict patterns of growth and body composition in infancy and childhood. In this paper we examined the relationship between maternal glycemia and neonatal adiposity and compared fasting with postchallenge glucose levels in influencing excessive neonatal adiposity outcomes in Asian mothers.
Materials and Methods

Study population
Pregnant women (18 y old and older) in their first trimester were recruited from the two major public hospitals with obstetric services in Singapore, the KK Women's and Children's Hospital and National University Hospital. Subjects approached were Singapore citizens or permanent residents who were of Chinese, Malay, or Indian ethnicity with homogeneous parental ethnic background, had the intention of delivering in National University Hospital or KK Women's and Children's Hospital, and were residing in Singapore for the next 5 years. Those who were on chemotherapy, psychotropic drugs, or diabetes mellitus were excluded from the study. Of the 3751 screened, 2034 met these criteria and 1247 women (response rate 61.3%) were recruited. Informed written consent was obtained from each participant on the day of the study. This study was approved by both the National Healthcare Group Domain Specific Review Board and the Sing Health Centralized Institutional Review Board.
Oral glucose tolerance testing
Participants underwent a 75-g oral glucose tolerance test (OGTT) after an overnight fast between 26 and 28 weeks of gestation, and venous glucose was measured by colorimetry [Advia 2400 Chemistry system (Siemens Medical Solutions Diagnostics) and Beckman LX20 Pro analyzer (Beckman Coulter)]. During the study period, glucose management was performed when mothers were diagnosed with hyperglycemia by current World Health Organization criteria (fasting or 2 h plasma glucose concentrations greater than 7.0 or 7.8 mmol/L, respectively). Results of the study were communicated to health practitioners, and mothers who were positively diagnosed were placed under either a diet or insulin treatment for management. One hundred ninety subjects (17.6%) had received glucose management treatment during the study period, of which 181 subjects had a 2-hour plasma glucose level that was above the threshold. Mothers with elevated fasting or 2-hour plasma glucose were subjected to the same glucose management protocol. Maternal height, weight, mid-upper arm circumference, and four skinfolds (triceps, biceps, subscapular, suprailiac) were measured during this visit. Questionnaires were administered during the visit to ascertain demographics, social economic status, lifestyle, maternal well-being, obstetric and medical histories, and use of medicines and supplements.
Neonatal anthropometry measurements
Neonatal anthropometric measurements included birth weight and length and skinfold measurements at two sites (triceps and subscapular). Infant birth weight was measured to the nearest gram using a calibrated scale (SECA 334 weighing scale; SECA Corp) for weighing the infant. Recumbent birth length was measured from the top of the head to the soles of the feet using an infant mat (SECA 210 mobile measuring mat; SECA Corp) to the nearest 0.1 cm. Percentage body fat (%BF) was measured in a subset of the neonates (n ϭ 337) using the PEA POD system (PEA POD; Life Measurement Inc), which measures the infant's body composition calculated from the body density. This was used to derive the standard centile charts for this study. For all infants, two skinfolds (triceps and subscapular) were measured in triplicate using Holtain skinfold calipers (Holtain Ltd) on the right side of the body, recorded to the nearest 0.2 mm. The following validated equation (13) recently derived from our GUSTO cohort was used to predict the neonatal fat mass:
fat mass ϭ Ϫ0.022 ϩ (0.307 * weight) Ϫ (0.077 * gender) ϩ (0.028 * subscapular skinfolds) Ϫ (0.019 * gestational age) where gender ϭ 1 for male, 0 for female. 
Definition of excessive neonatal adiposity outcomes
Large-for-gestational age (birth weight > 90th centile)
Centile charts for three newborn gender-ethnic groups (Chinese, Malay, and Indian) in the GUSTO cohort with gestational ages of 34 -41 weeks were determined using the method of smooth L curve, median, and coefficient of variation (14) . This method estimates the anthropometric measurement centiles in terms of three age-sex specific cubic spline curves: L curve (measure of skewness based on the Box-Cox transformation), M curve (median), and the S curve (coefficient of variation). A newborn would be considered to have birth weight above the 90th percentile if the weight was greater than the 90th centile for the infant's gender and gestational age.
The %BF greater than the 90th centile is as follows: %BF above the 90th centile was defined using the same methods as for birth weight greater than the 90th centile, with gestational ages of 34 -41 weeks included.
Sum of skinfolds (ΑSFT) greater than the 90th centile is as follows: ΑSFT above the 90th centile was defined using the same methods as for %BF greater than the 90th centile, with gestational ages of 34 -41 weeks included.
Statistical analyses
Descriptive statistics were reported as means and SDs for continuous variables and percentages for categorical variables. Differences in demographic and clinical characteristics across ethnicities were calculated using 2 analysis and one-way ANOVA. Fasting and 2-hour glucose measurements were divided into six categories, adapted from the HAPO Study protocol (7). For fasting glucose the following were used: category 1 (Ͻ4.2 mmol/L); category 2 (4.2-4.4); category 3 (4.5-4.7); category 4 (4.8 -4.9); category 5 (5.0 -5.2); and category 6 (Ն5.3). For the 2-hour glucose level during OGTT the following were used: category 1 (Ͻ5.1 mmol/L); category 2 (5.1-6.0); category 3 (6.1-6.9); category 4 (7.0 -7.7); category 5 (7.8 -8.7); and category 6 (Ն8.8).
For analyses of associations of maternal glycemia with excessive neonatal adiposity, each glucose measurement was considered as a categorical and continuous variable. As a categorical variable, odds ratios were calculated for each measure of fasting and 2-hour glucose, higher by one category (categories 2-6), with reference to the lowest glucose category (category 1). For glucose as a continuous variable, odds ratios were calculated for each measure of fasting and 2-hour glucose higher by 1 U (ie, 1 mmol/L) and also by 1 SD score (SDS). For each outcome, two logistic regression models were used for calculation of odds ratios, with model I including adjustment for variables used to define the 90th centile (ie, gender and gestational age at delivery) and model II including additional adjustment for maternal age, body mass index (BMI) at time of the OGTT, education (below or above A levels/diploma), parity (nulliparous or multiparous), and ethnicity (Chinese, Malay, Indian). To account for the impact of ethnic differences in socioeconomic status on the outcome, an interaction term between education and ethnicity was included as a covariate in the model. All analysis was performed using SPSS version 19.0 (IBM, SPSS Statistics).
Results
A total of 1247 eligible pregnant mothers were recruited to the study and data on glucose levels were available for 1081 subjects. Characteristics of these participants are shown in Table 1 ; 57.2% were Chinese, 25.5% Malay, and 17.3% Indian. Mean maternal BMI at the time of the OGTT was 26.2 kg/m Ϫ2 ; the mean glucose levels for the participants were 4.4 and 6.6 mmol/L for the fasting and 2-hour plasma glucose level, respectively. Mean gestational age at delivery was 38.2 weeks and the mean birth weight was 3089 g. Skinfold measurements were available for 959 infants whose mothers had corresponding glucose measurements.
Overall, we observed that the frequency of excessive neonatal adiposity outcomes rose in a linear fashion across increasing fasting and 2-hour glucose categories, even across the normal range ( Figure 1, A-C) . The proportion of infants increased from 7.1% to 26.8% for large for gestational age (LGA), 2.4% to 17.9% for %BF greater than the 90th centile and 7.7% to 38.2% for ΑSFT greater than the 90th centile across six fasting glucose categories. Across 2-hour glucose categories, the proportion of infants increased from 6.1% to 17.9% for LGA, 0.7% to 8.0% for %BF greater than the 90th centile, and 4.5% to 18.3% for ΑSFT greater than the 90th centile. A 2 test revealed a significant linear trend for all three excessive adiposity outcomes only for fasting glucose ( 2 ϭ 30.08 for LGA, 2 ϭ 25.26 for ΑSFT greater than the 90th percentile, 2 ϭ 39.73 for ΑSFT greater than the 90th percentile; P Ͻ .0005 for all three outcomes) but not for 2-hour glucose. To test for the possible nonlinear relationship between fasting glucose and birth size, squared terms for fasting glucose SDS was added to a regression model; the coefficient of the squared fasting glucose term was not statistically significant, hence highlighting that the relationship between fasting glucose and birth size is not nonlinear.
The associations of maternal glucose with excessive neonatal adiposity outcomes are illustrated in Table 2 , including odds ratios (ORs) and 95% confidence intervals for each category compared with the lowest category. For all three measures of excessive neonatal adiposity, we observed a continuous and graded association across increasing levels of maternal glycemia for both fasting and 2-hour glucose. For the outcome of LGA in model I, the OR was 4.18 for highest category for fasting glucose and 3.18 for highest 2-hour glucose category; there was modest attenuation of the odds ratios with adjustment for ad-ditional confounders in model II for both glucose measures. For %BF and ΑSFT greater than the 90th centile, the ORs for fasting glucose were attenuated but became larger for 2-hour glucose. ORs of having LGA and ΑSFT greater than the 90th centile were elevated within the normal fasting glucose range (category 4, 4.8 -4.9 mmol/L) and also for the outcome of %BF and ΑSFT greater than the 90th percentile for normal 2-hour glucose range of 6.1-7.7 mmol/L (categories 3 and 4). Additionally, we observed significant trends (P Ͻ .0005) of increasing likelihood of having LGA, %BF, and ΑSFT Ͼ 90th centile with fasting glucose levels in six increasing categories; on the contrary, no significant trend was observed for likelihood of having excessive adiposity outcomes with increasing 2-hour glucose categories.
We also analyzed the relationships between maternal glucose analyzed as a continuous variable and excessive neonatal adiposity outcomes; each 1 mmol/L increase in fasting glucose was associated with 1.64 [95% confidence interval (CI) 1.20 -2.25], 2.73 (95% CI 1.64 -4.53), and 2.50 (95% CI 1.68 -3.71) increases in ORs for LGA and %BF and ΑSFT greater than the 90th centile, respectively. Corresponding ORs for 2-hour glucose were 1.07 (95% CI 0.95-1.19), 1.32 (95% CI 1.06 -1.64), and 1.24 (95% CI 1.06 -1.44), respectively. For all three measures of excessive neonatal adiposity, there were significant associations with both measures of maternal glycemia, except for the relationship between 2-hour glucose and LGA. We also noted that the strength of association between fasting glucose and excessive neonatal adiposity was greater for all three outcomes as compared with 2-hour glucose. In view of the greater variability in measurement for 2-hour glucose, we also analyzed the odds ratios of having excessive adiposity outcomes for each measure of glucose higher by 1 SDS. Each 1 SDS increase in fasting glucose was associated with 1.31 (95% CI 1.10 -1.55), 1.72 (95% CI 1.31-2.27), and 1.64 (95% CI 1.32-2.03) increases in ORs for LGA and %BF and ΑSFT greater than the 90th centile, respectively (Table 3) . Corresponding ORs for 2-hour glucose were 1.11 (95% CI 0.92-1.33), 1.55 (95% CI 1.10 -2.20), and 1.40 (95% CI 1.10 -1.79), respectively (Table 3) . Similarly, we noted that for all three measures of excessive neonatal adiposity, there were significant associations with both measures of maternal glycemia, except for the relationship between 2-hour glucose and LGA. Additionally, there were no significant nonlinear associations for both glucose measures. When birth weight, %BF, and ΑSFT were modeled as continuous variables in multiple linear regression analyses with adjustment for the same confounders in model II, mean differences between the higher (categories 2-6) and lowest categories (category 1) for both glucose measures ranged between 0.03 and 0.18 kg for birth weight, between 0.17% and 1.90% for %BF, and between 0.12 and 1.58 mm for ΑSFT (P Ͻ .05 for both glucose measures in all outcomes). Additionally, we identified a significant negative interaction [B ϭ Ϫ2.65 (95% CI Ϫ4.49 -0.81), P ϭ .005] between high fasting glucose levels (category 6) with Indian ethnicity (relative to Chinese), in relation to outcome of ΑSFT. Compared with Chinese, Indians with high fasting glucose levels (category 6) are associated with lesser increase in neonatal ΑSFT. A subgroup analysis among women of the three ethnic groups with abnormally high glucose levels (ie, fasting or 2 h OGTT category Ն 5) also identified a significant interaction between fasting glucose with Indian ethnicity [B ϭ Ϫ0.71 (95% CI Ϫ1.41-0.02), P ϭ .032] for the outcome of ΑSFT. Compared with Chinese, every SD increase in fasting glucose in Indians is associated with lesser increase in neonatal ΑSFT; these are demonstrated graphically in Supplemental Figure 1 , published on The Endocrine Society's Journals Online web site at http://jcem.endojournals.org. No significant interactions were noted for 2-hour glucose with ethnicity in relation to excessive neonatal adiposity outcomes within the same subgroup.
Discussion
Our findings in this study have demonstrated a continuous association between maternal glycemia and measures of excessive neonatal adiposity. The relationship was present for each maternal glucose measurement and persisted, even when potential confounders such as BMI, age, ethnicity, gestational age, and socioeconomic status were taken into account. First, consistent with that of the HAPO study (6), we observed that maternal glucose measured at a single point during pregnancy was effective in identifying excessive neonatal adiposity outcomes. Second, we noted that the relationship was graded across the range of maternal glucose levels. Hence, maternal glycemia appears to influence neonatal adiposity not just at high glucose levels but also across the normal range of glucose. In our cohort, we noted significant increases in excessive adiposity outcomes at glucose levels below those defined as hyperglycemia, similar to findings from the HAPO study.
Interestingly, in our cohort we noted that the trend of graded increases in the frequency and likelihood of excessive neonatal adiposity outcomes across the range of maternal glucose categories were significant only for fasting glucose but not for 2-hour glucose. Significant interactions for fasting glucose and Indian ethnicity in relation to ΑSFT greater than the 90th percentile were also observed, especially among the subgroup of women with abnormally high glucose levels. Collectively our results led us to speculate that fasting glucose might have a greater influence on excessive neonatal adiposity outcomes compared with postchallenge glucose and that the influence of raised maternal fasting glucose levels on neonatal ΑSFT may be 2), and category 6 (Ն5.3). For 2-hour glucose levels during OGTT the following were used (in millimoles per liter): category 1 (Ͻ5.1), category 2 (5.1-6.0), category 3 (6.1-6.9), category 4 (7.0 -7.7), category 5 (7.8 -8.7), and category 6 (Ն8.8).
less pronounced for Indian mothers compared with Chinese mothers. We observed that among all three ethnic groups, Malays formed the significantly smallest proportion (10.5%) that received management for gestational diabetes compared with Chinese and Indians, who appear to have relatively similar proportions that had received management (Chinese 19.3% vs Indians 22.6%); this suggests that glucose management may not have confounded the ethnic difference between Indians and Chinese in the relationship between maternal glycemia and excessive neonatal adiposity outcomes that were observed in our study. The observed effect of ethnicity on the relationship between maternal glycemia and excessive neonatal adiposity may also imply the possibility of having different glucose management thresholds according to ethnicity.
There have been documented reports of fasting glucose better identifying the risk of macrosomia or excessive adiposity outcomes, as highlighted in recent studies by Ben Haroush et al (15) and Disse et al (16) . In our study, although the variability in measurement for 2-hour glucose was larger, the strength of association between maternal glycemia with excessive adiposity outcomes was slightly greater for fasting glucose as compared with 2-hour glucose when considered as SDS. Fasting glucose SDS was also significantly associated with all three measures of excessive neonatal adiposity; 2-hour glucose, however, showed no significant relationship with LGA. As such, our findings may highlight that fluxes of maternal glucose during the fasting state may have a slightly greater influence on excessive adiposity outcomes; nonetheless, our findings still illustrate that the dose-response effect of maternal glycemia on excessive neonatal adiposity is continuous across all glucose levels. The classic Pedersen's hypothesis postulated that maternal hyperglycemia transmitted to the fetus would result in fetal hyperinsulinemia (17) , which in turn can attribute to increased fetal fat accretion (18) . His findings, however, were based on women with type 1 diabetes; over the years, there have been increases in the occurrences of GDM and type 2 diabetes (19) . The underlying physiology of type 1 diabetes and type 2 diabetes/GDM are fundamentally different, and as such, the metabolic environment that the developing fetus is exposed to would be different (20) . Thus, the finding of a continuous association between maternal glycemia and neonatal adiposity provides us with a better understanding of the influence of maternal glycemia, with the effect not only restricted to maternal hyperglycemia but also extending throughout the range of glycemia. Other than the recent HAPO study, there are few published studies relating maternal metabolic factors with neonatal body composition. Past studies that have identified relationships between birth size and later adiposity are also based primarily on birth weight without any information regarding adiposity at birth (2) . Thus, our study provides useful, informative data on the relationship between maternal glycemia and neonatal body composition in a multiethnic cohort independent from the HAPO study and the consistency in the findings from both cohorts confirm the link between maternal glycemia and neonatal adiposity.
Our study has some limitations. Glucose data were collected only at fasting and 2-hour postchallenge but not at 1-hour postchallenge. Data on 1-hour glucose would have allowed us to better address the role of maternal glycemia with neonatal adiposity. Also, %BF was not measured directly, but estimated using an equation based on the infant's gender, gestational age, weight, and subscapular skinfold thickness (13) . Skinfold thickness is an indirect measure of adiposity; however, the formula has been validated by infant body composition measurements with PEA POD (Life Measurement Inc).
In conclusion, our study involving an Asian population revealed a continuous dose-response relationship between maternal glycemia and neonatal adiposity, which extends across the entire range of glycemia. The consistency of our findings with the HAPO study also confirms the link between maternal glycemia and neonatal adiposity. It remains to be seen whether the observed association between maternal metabolic factors and neonatal body composition has long-term repercussions on the increasing prevalence of obesity and diabetes in adolescents as well as adults.
